William B Wong - JoVE Visualize

Showing results (21-30 of 30) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 30 results.

Contemporary Clinical Trials|September 18, 2012

The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)William B Wong, Scott D Ramsey, William E Barlow, et al.

Cancer Research Communications|January 26, 2024

Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing PanelsYiqing Zhao, Anastasios Dimou, Zachary C Fogarty, et al.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021

Modeling the Ex Post Real Option Value in Metastatic Melanoma Using Real-World DataWoojung Lee, Meng Li, William B Wong, et al.

Journal of Managed Care & Specialty Pharmacy|August 25, 2021

Real-world evidence for option value in metastatic melanomaWilliam B Wong, Tu My To, Meng Li, et al.

JCO Precision Oncology|May 26, 2021

Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health PlansEleanor O Caplan, William B Wong, Erin Ferries, et al.

Advances in Therapy|December 28, 2020

Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource UtilizationDaniel M Sheinson, William B Wong, Caroline E Solon, et al.

Molecular Pharmacology|August 25, 2004

The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responsesSushil K Mahata, Manjula Mahata, Gen Wen, et al.

Journal of Oncology Practice|September 13, 2019

Are National Comprehensive Cancer Network Evidence Block Affordability Ratings Representative of Real-World Costs? An Evaluation of Advanced Non-Small-Cell Lung CancerJoshua T Cohen, Pei-Jung Lin, Daniel M Sheinson, et al.

JAMA Network Open|December 9, 2021

Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage DeterminationDaniel M Sheinson, William B Wong, Craig S Meyer, et al.

Journal of Comparative Effectiveness Research|August 24, 2021

Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in <i>ROS1</i>+ NSCLCRobert C Doebele, Laura Perez, Huong Trinh, et al.

Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 30 results.

Contemporary Clinical Trials|September 18, 2012

The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)William B Wong, Scott D Ramsey, William E Barlow, et al.

Cancer Research Communications|January 26, 2024

Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing PanelsYiqing Zhao, Anastasios Dimou, Zachary C Fogarty, et al.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021

Modeling the Ex Post Real Option Value in Metastatic Melanoma Using Real-World DataWoojung Lee, Meng Li, William B Wong, et al.

Journal of Managed Care & Specialty Pharmacy|August 25, 2021

Real-world evidence for option value in metastatic melanomaWilliam B Wong, Tu My To, Meng Li, et al.

JCO Precision Oncology|May 26, 2021

Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health PlansEleanor O Caplan, William B Wong, Erin Ferries, et al.

Advances in Therapy|December 28, 2020

Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource UtilizationDaniel M Sheinson, William B Wong, Caroline E Solon, et al.

Molecular Pharmacology|August 25, 2004

The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responsesSushil K Mahata, Manjula Mahata, Gen Wen, et al.

Journal of Oncology Practice|September 13, 2019

Are National Comprehensive Cancer Network Evidence Block Affordability Ratings Representative of Real-World Costs? An Evaluation of Advanced Non-Small-Cell Lung CancerJoshua T Cohen, Pei-Jung Lin, Daniel M Sheinson, et al.

JAMA Network Open|December 9, 2021

Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage DeterminationDaniel M Sheinson, William B Wong, Craig S Meyer, et al.

Journal of Comparative Effectiveness Research|August 24, 2021

Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in <i>ROS1</i>+ NSCLCRobert C Doebele, Laura Perez, Huong Trinh, et al.

Pageof 3